Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Mendlein currently holds 25,000 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Mendlein has been a net buyer of LIFE stock. They have purchased $1.2M and sold $1.1M worth of shares.
John Mendlein's most recent insider trade was on Jun 20, 2024, when they sold 25,000 shares at $0.00 per share.
John Mendlein serves as Executive at aTYR PHARMA INC (LIFE). They have executed 22 insider transactions totaling $2.3M over their tenure at the company.
John Mendlein holds the position of Executive at aTYR PHARMA INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 13 years and currently hold a stake valued at $0.
John Mendlein has shown a buying trading pattern, with $1.2M in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John Mendlein was on Mar 10, 2022, when they sold $677.0K worth of FATE shares. This transaction involved 19,493 shares at $34.73 per share.
John Mendlein currently owns 25,000 shares of aTYR PHARMA INC (LIFE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Mendlein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Mendlein has 22 Form 4 filings on record as an insider at aTYR PHARMA INC.
Set alerts for John Mendlein and 40,000+ other insiders.